Literature DB >> 2875396

Sodium regulation of agonist and antagonist binding to beta-adrenoceptors in intact and Ns-deficient membranes.

M Minuth, K H Jakobs.   

Abstract

Agonist binding to various hormone receptors mediating adenylate cyclase inhibition is decreased by sodium ions. We studied the influence of Na+ on agonist and antagonist binding to beta-adrenoceptors in membrane preparations of guinea pig lung, S49 lymphoma wild-type cells (WT) and their Ns-deficient cyc- variants by measuring binding of the antagonist, [125I]iodocyanopindolol [( 125I]CYP). At 37 degrees C, sodium decreased the receptor affinity for the agonist, isoproterenol, in all three membrane preparations. In lung and WT membranes, Na+ steepened the shallow agonist competition curves in a manner similar to and synergistic with guanine nucleotides. When binding was performed at 4 degrees C, sodium regulation but not guanine nucleotide regulation of agonist binding was preserved. At the low temperature, [125I]CYP affinity was reduced, and sodium increased [125I]CYP binding in both Ns-containing and Ns-deficient membranes by increasing the antagonist affinity without significant change in total receptor number. Compared to Na+, Li+ and K+ were much less potent and efficient in decreasing agonist and increasing antagonist binding. Na+ and Mg2+ had opposite effects on agonist binding in the Ns-containing lung and WT membranes but not in the Ns-deficient cyc- membranes. The data indicate that sodium not only regulates binding of inhibitory hormone receptors but also agonist and antagonist binding to the adenylate cyclase stimulatory beta-adrenoceptor. The finding that sodium regulation of beta-adrenoceptor binding is also observed in the Ns (alpha s)-deficient cyc- membranes, furthermore, indicates that the target of sodium is not the alpha-subunit of Ns but possibly a component common to both types of receptor systems regulating adenylate cyclase activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875396     DOI: 10.1007/bf00506514

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  22 in total

1.  Agonist-specific effects of monovalent and divalent cations on adenylate cyclase-coupled alpha adrenergic receptors in rabbit platelets.

Authors:  B S Tsai; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1978-07       Impact factor: 4.436

2.  Relationship between the beta-adrenergic receptor and adenylate cyclase.

Authors:  E M Ross; M E Maguire; T W Sturgill; R L Biltonen; A G Gilman
Journal:  J Biol Chem       Date:  1977-08-25       Impact factor: 5.157

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  (+/-)-[3H]Epinephrine and (-)[3H]dihydroalprenolol binding to beta1- and beta2-noradrenergic receptors in brain, heart, and lung membranes.

Authors:  D C U'Prichard; D B Bylund; S H Snyder
Journal:  J Biol Chem       Date:  1978-07-25       Impact factor: 5.157

5.  Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor.

Authors:  G A Weiland; K P Minneman; P B Molinoff
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

6.  No evidence for temperature-dependent changes in the pharmacological specificity of beta 1- and beta 2-adrenoceptors in rabbit lung membranes.

Authors:  O E Brodde; F Kuhlhoff; J Arroyo; A Prywarra
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-02       Impact factor: 3.000

7.  Sodium ion modulates agonist and antagonist interactions with the human platelet alpha 2-adrenergic receptor in membrane and solubilized preparations.

Authors:  L E Limbird; J L Speck; S K Smith
Journal:  Mol Pharmacol       Date:  1982-05       Impact factor: 4.436

8.  Cardiac muscarinic cholinergic receptor binding is regulated by Na+ and guanyl nucleotides.

Authors:  L B Rosenberger; H I Yamamura; W R Roeske
Journal:  J Biol Chem       Date:  1980-02-10       Impact factor: 5.157

9.  Differential regulation of the alpha 2-adrenergic receptor by Na+ and guanine nucleotides.

Authors:  T Michel; B B Hoffman; R J Lefkowitz
Journal:  Nature       Date:  1980-12-25       Impact factor: 49.962

10.  Characterization of radiolabeled agonist binding to beta-adrenergic receptors in mammalian tissues.

Authors:  K A Heidenreich; G A Weiland; P B Molinoff
Journal:  J Cyclic Nucleotide Res       Date:  1980
View more
  6 in total

Review 1.  Biotechnology of beta-adrenergic receptors.

Authors:  A D Strosberg
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

2.  Characterization of the binding of a novel radioligand to CCKB/gastrin receptors in membranes from rat cerebral cortex.

Authors:  E A Harper; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

3.  Mono- and divalent cations modulate the affinities of brain D1 and D2 receptors for dopamine by a mechanism independent of receptor coupling to guanyl nucleotide binding proteins.

Authors:  S Urwyler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

Review 4.  Beta-adrenoceptor responsiveness in hypertension: effects of dietary NaCl intake.

Authors:  R D Feldman
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

5.  Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet.

Authors:  R D Feldman
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

6.  The 2.1 Å resolution structure of cyanopindolol-bound β1-adrenoceptor identifies an intramembrane Na+ ion that stabilises the ligand-free receptor.

Authors:  Jennifer L Miller-Gallacher; Rony Nehmé; Tony Warne; Patricia C Edwards; Gebhard F X Schertler; Andrew G W Leslie; Christopher G Tate
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.